October 14, 2026

COST Action News

The Memorandum of Understanding (MoU) of CardioPharmaGENET (CA24165) has been published in the Journal of Molecular and Cellular Cardiology Plus. The publication presents the COST Action network and its mission to advance cardiovascular pharmacogenomics and precision medicine through multidisciplinary collaboration, knowledge exchange, capacity building, and translation of research into clinical practice. Read the full publication:…

On 10 September 2026, COST Actions CardioPharmaGENET (CA24165) and INFLAMomx (CA24166) successfully organised the joint webinar “Precision Medicine at the Crossroads of Cardiovascular Disease and Inflammation.” The online event brought together 85 participants for an interdisciplinary discussion on the connections between cardiovascular disease, chronic inflammation, and precision medicine. Moderated by Dr. Yvan Devaux, the webinar…

The first day of the CA24167 HUMAN-IT Core Group and WG Leadership Meeting took place at the National University of Political Studies and Public Administration (SNSPA) in Bucharest, bringing together Core Group members, Working Group leaders and Subgroup leaders. The meeting opened with a review of the overall implementation of the Action and the main…